Skip to content
Preprint · CC-BY via OpenAlex

Procyanidin C1: A Natural Dual‑Mode Senotherapeutic for Pan‑Organ Senescence Modulation and Clearance

Jiaxin Liang, Qun Wang, Jie Li, Qinghua Lyu, Tszho Yip

Preprints.org · 2025

Abstract

Cellular senescence(definition) is driven by DNA damage, telomere(definition) attrition, and metabolic/mitochondrial stress, culminating in a state of durable proliferative arrest accompanied by a senescence-associated secretory phenotype (SASP) that amplifies inflammation and paracrine remodeling across tissues, thereby accelerating functional decline and age-related pathologies. This review examines the molecular mechanisms and in vivo activities of procyanidin C1 (PCC1), a natural dualmode senotherapeutic. Its dual behavior is characterized by an early or lowdose phase in which PCC1 attenuates selected NFκB–driven SASP components while stabilizing redox and bioenergetic homeostasis; under high senescent burden or tumor-associated stress, elevated doses of PCC1 enable the selective reduction of refractory senescent cells and mitigation of pro-tumorigenic SASP outputs, concomitant with modulation of immune infiltration and metabolic reprogramming. PCC1 further exhibits pronounced anti-inflammatory and anti-tumor potential by reshaping inflammatory and chemotactic gradients within the tumor microenvironment. Reflecting broad multi-organ geroprotective activity, PCC1 can exert antioxidative, mitochondrial-supportive, and anti-fibrotic modulation in cardiovascular/metabolic tissues, skin, liver, kidney, and neural niches. Compared with BCL-2 inhibitors or multi-kinase senolytics(definition), PCC1 shows lower cytotoxicity toward normal proliferating cells and fewer indications of platelet or hematopoietic suppression, with its staged regulatory profile and natural scaffold suggesting a wider therapeutic window. Future priorities include quantifying dose–timing transition thresholds, establishing integrated biomarker panels, and optimizing delivery strategies to define its translational potential in precision, phase-adapted senescence and tumor microenvironment interventions.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.20944/preprints202509.1608.v1
Canonical
link ↗
Fetched
2026-10-12 MST

Cite this

APA
Liang, J., Wang, Q., Li, J., Lyu, Q., &amp; Yip, T. (2025). Procyanidin C1: A Natural Dual‑Mode Senotherapeutic for Pan‑Organ Senescence Modulation and Clearance. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202509.1608.v1
Vancouver
Liang J, Wang Q, Li J, Lyu Q, Yip T. Procyanidin C1: A Natural Dual‑Mode Senotherapeutic for Pan‑Organ Senescence Modulation and Clearance. Preprints.org. 2025. doi:10.20944/preprints202509.1608.v1.
BibTeX
@unpublished{jiaxin2025Procya, title = {Procyanidin C1: A Natural Dual‑Mode Senotherapeutic for Pan‑Organ Senescence Modulation and Clearance}, author = {Jiaxin Liang and Qun Wang and Jie Li and Qinghua Lyu and Tszho Yip}, journal = {Preprints.org}, year = {2025}, doi = {10.20944/preprints202509.1608.v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings